MOZ, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 5.187
EU - Europa 719
AS - Asia 642
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 3
OC - Oceania 2
Totale 6.569
Nazione #
US - Stati Uniti d'America 5.178
CN - Cina 459
IT - Italia 214
FI - Finlandia 153
SE - Svezia 136
VN - Vietnam 79
DE - Germania 59
GB - Regno Unito 56
SG - Singapore 40
UA - Ucraina 34
HK - Hong Kong 21
IN - India 17
EU - Europa 15
FR - Francia 14
RU - Federazione Russa 14
KR - Corea 12
NL - Olanda 12
CA - Canada 9
GR - Grecia 8
IE - Irlanda 7
ID - Indonesia 6
RO - Romania 6
IQ - Iraq 3
JP - Giappone 3
AU - Australia 2
BE - Belgio 2
CL - Cile 2
ES - Italia 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
AT - Austria 1
CZ - Repubblica Ceca 1
IR - Iran 1
Totale 6.569
Città #
Fairfield 649
Woodbridge 611
Ann Arbor 570
Houston 536
Chandler 523
Ashburn 354
Cambridge 252
Wilmington 227
Seattle 220
Jacksonville 136
Princeton 114
Des Moines 111
Medford 101
Beijing 91
Dong Ket 79
Nanjing 68
Padova 68
Helsinki 63
San Diego 54
Roxbury 53
Boardman 47
Shenyang 29
Jinan 28
Hebei 25
Singapore 23
Nanchang 21
Hong Kong 20
Changsha 19
Guangzhou 19
Los Angeles 18
Tianjin 15
Jiaxing 14
New York 14
Zhengzhou 14
Shanghai 13
Nowon-gu 12
London 11
Redwood City 10
Taizhou 10
Milan 9
Pune 9
Casier 8
Hefei 8
Kunming 8
Dublin 7
Fisciano 7
Haikou 7
Lanzhou 7
Cagliari 6
Indiana 6
Indianapolis 6
Ningbo 6
Florence 5
Hangzhou 5
Limena 5
Norwalk 5
Bologna 4
Borås 4
Fuzhou 4
Kilburn 4
Lappeenranta 4
Mestre 4
Montreal 4
Ogden 4
Paris 4
Phoenix 4
Rome 4
Dearborn 3
Detroit 3
Kharkiv 3
Malo 3
Mestrino 3
Rockville 3
Taiyuan 3
Tappahannock 3
Tortoreto 3
Verona 3
Washington 3
Wuhan 3
Yellow Springs 3
Adelfia 2
Aprilia 2
Baotou 2
Chengdu 2
Chicago 2
Chiyoda-ku 2
Frankfurt am Main 2
Fremont 2
Genoa 2
Groningen 2
Hamburg 2
Hounslow 2
Malang 2
Marcon 2
Munich 2
New Bedfont 2
North York 2
Pontecorvo 2
Prescot 2
Samos 2
Totale 5.479
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 154
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 154
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 139
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 137
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 137
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 124
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors 123
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 120
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 116
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 114
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 113
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 101
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 99
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 98
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 97
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 92
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 89
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 83
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 83
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 82
Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling 82
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFa therapy 81
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 80
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 80
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 78
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 78
VITAMIN D:FOE OF THE IMMUNE RESPONSE IN PANCREATIC CANCER 78
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 73
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 73
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 73
Emerging role of monocytes and of their intracellular calcium content in spondyloarthritis 73
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 71
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 70
Maldi-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and Complement C3. 69
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 68
Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer. 68
NT-S100A8 effects on cell signalling. 67
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 67
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 67
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 67
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 66
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 63
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 63
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 63
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 62
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 62
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 60
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 60
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 59
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 59
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 59
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 57
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 56
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 56
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 54
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 53
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 53
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 52
Vitamin D prevents pancreatic cancer-induced apoptosis signaling of inflammatory cells 52
Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study 52
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 51
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 51
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 50
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 50
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 50
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 49
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 49
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 48
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 48
Emerging role of monocytes and their intracellular calcium pattern in spondyloarthritis 48
PRE-ANALYTICAL EFFECTS ON ESTABLISHED AND EMERGING BIOMARKERS OF CARDIOVASCULAR DISEASE (CVD) 46
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 45
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 45
Genome-wide association study identifies an early onset pancreatic cancer risk locus 45
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 44
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 44
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 43
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 43
Effectiveness of the combined evaluation of KLK3 genetics and f/tPSA ratio for prostate cancer diagnosis 43
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 41
The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave 41
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 40
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 40
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 40
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 38
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 37
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 36
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 36
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 35
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 34
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 34
The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-b1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling. 32
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 31
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 30
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 29
SMAD4 Deletion and EGF Co-Operate in Favoring mTOR Activation in PDAC Cells 29
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 29
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus. 28
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 27
SMAD4 LOSS ENABLES EGF, TGFB1 AND S100A8/ A9 INDUCED ACTIVATION OF CRITICAL PATHWAYS TO PANCREATIC CANCER INVASION 27
Totale 6.485
Categoria #
all - tutte 20.882
article - articoli 11.516
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019182 0 0 0 0 0 0 0 0 0 0 0 182
2019/20201.095 183 30 12 52 106 83 94 112 113 190 76 44
2020/2021965 33 52 83 120 53 51 31 54 108 144 102 134
2021/2022998 14 173 68 56 36 77 28 98 55 11 94 288
2022/20231.116 203 107 13 129 194 159 10 76 148 9 38 30
2023/2024594 21 70 66 50 47 64 64 77 21 50 51 13
Totale 6.637